Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 4:10:329.
doi: 10.3389/fneur.2019.00329. eCollection 2019.

Adults With Complex Congenital Heart Disease: Cerebrovascular Considerations for the Neurologist

Affiliations
Review

Adults With Complex Congenital Heart Disease: Cerebrovascular Considerations for the Neurologist

Jonathan M C Smith et al. Front Neurol. .

Abstract

As infant and childhood mortality has decreased in congenital heart disease, this population is increasingly reaching adulthood. Adults with congenital heart disease (ACHD) represent a group with increased risk of stroke, silent brain infarcts, and vascular cognitive impairment. Cyanotic and other complex cardiac lesions confer the greatest risk of these cerebrovascular insults. ACHD patients, in addition to having an increased risk of stroke from structural cardiac issues and associated physiological changes, may have an accelerated burden of conventional vascular risk factors, including hypertension and impaired glucose metabolism. Adult neurologists should be aware of the risks of clinically evident and subclinical cerebrovascular disease in this population. We review the existing evidence on primary and secondary stroke prevention in individuals with complex congenital heart disease, and identify knowledge gaps in need of further research, including treatment of acute stroke in this population. Multisystemic genetic syndromes are outside the scope of this review.

Keywords: Adults with Congenital Heart Disease (ACHD); Cardiovascular Disease; Cerebrovascular disease; Congenital Heart Disease (CHD); cognition; cyanotic; fontan; stroke.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Improved survival of people affected by CHD [data from Knowles et al. (23)].
Figure 2
Figure 2
Relative prevalence of congenital heart lesions [data from Hoffman and Kaplan (13)].
Figure 3
Figure 3
Mechanisms of cerebrovascular disease in ACHD.

References

    1. van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, et al. . Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. (2011) 58:2241–7. 10.1016/j.jacc.2011.08.025 - DOI - PubMed
    1. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. . Heart disease and stroke statistics-2017 update: a report from the american heart association. Circulation. (2017) 135:e146–603. 10.1161/CIR.0000000000000485 - DOI - PMC - PubMed
    1. Gilboa SM, Devine OJ, Kucik JE, Oster ME, Riehle-Colarusso T, Nembhard WN, et al. . Congenital heart defects in the United States: estimating the magnitude of the affected population in 2010. Circulation. (2016) 134:101–9. 10.1161/CIRCULATIONAHA.115.019307 - DOI - PMC - PubMed
    1. Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol. (2010) 56:1149–57. 10.1016/j.jacc.2010.03.085 - DOI - PubMed
    1. Lanz J, Brophy JM, Therrien J, Kaouache M, Guo L, Marelli AJ. Stroke in adults with congenital heart disease: incidence, cumulative risk, and predictors. Circulation. (2015) 132:2385–94. 10.1161/CIRCULATIONAHA.115.011241 - DOI - PubMed